Why the study?
The causes of atherothrombosis remain elusive, and a comprehensive study of T cell-mediated immune responses in coronary thrombi from STEMI patients is lacking.
What are the single-cell characteristics and gene expression profiles of T lymphocytes in coronary thrombi and peripheral blood of STEMI patients compared to controls?
What are the single-cell characteristics and gene expression profiles of T lymphocytes in coronary thrombi and peripheral blood of STEMI patients compared to controls?
Answers are grounded in this paper and cite their sources.
Single-cell analysis reveals that T lymphocytes in STEMI patients undergo antigen-specific stimulation and clonal expansion, highlighting a potential adaptive immune mechanism driving atherothrombosis.
BACKGROUND: The occurrence and development of ST-segment elevation myocardial infarction (STEMI) are accompanied by coronary atherothrombosis and occlusion, and immune responses play prominent roles in their pathogeneses. However, the causes of atherothrombosis remain elusive, and a comprehensive study of T cell-mediated immune responses in coronary thrombi from STEMI patients is lacking. OBJECTIVES: T lymphocytes in STEMI patients at the single-cell level. METHODS: T lymphocytes in the coronary thrombi and peripheral blood of STEMI patients, as well as the blood from control subjects without coronary artery disease (CAD). RESULTS: T cells was increased. Compared with those from non-CAD controls, T lymphocytes from STEMI patients exhibited an upregulation of genes related to recent TCR engagement, suggesting antigen-specific stimulation in STEMI. Antigen specificity prediction using an algorithm indicated the probability of T cells from different patients binding to similar antigens for clonal expansion during STEMI. CONCLUSION: T lymphocytes in the coronary thrombi and peripheral blood of STEMI patients. Identifying the precise adaptive immune mechanisms driving atherothrombosis may lead to innovative therapies that selectively target the aberrant immune response, resulting in more effective treatments for STEMI.
No takes yet. Share an insight, caveat, or question.
Gu et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: